Cargando…
Zoledronate Attenuates Angiogenic Effects of Angiotensin II-Stimulated Endothelial Progenitor Cells via RhoA and MAPK Signaling
BACKGROUND: New vessel formation plays a pivotal role in the pathogenesis of neovascular-related diseases. Endothelial progenitor cells (EPCs) were found to contribute to neovascular-related diseases and interference with EPC neovascularization may be a novel target for these diseases. Zoledronate (...
Autores principales: | Yang, Jin-Xiu, Chen, Bin, Pan, Yan-Yun, Han, Jie, Chen, Fei, Hu, Shen-Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469623/ https://www.ncbi.nlm.nih.gov/pubmed/23071580 http://dx.doi.org/10.1371/journal.pone.0046511 |
Ejemplares similares
-
Carvedilol Inhibits Angiotensin II-Induced Proliferation and Contraction in Hepatic Stellate Cells through the RhoA/Rho-Kinase Pathway
por: Wu, Ying, et al.
Publicado: (2019) -
Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells
por: Hauke, Michael, et al.
Publicado: (2022) -
The role of RhoA/Rho kinase pathway in endothelial dysfunction
por: Yao, Lin, et al.
Publicado: (2010) -
RhoA GTPase controls cytokinesis and programmed necrosis of hematopoietic progenitors
por: Zhou, Xuan, et al.
Publicado: (2013) -
RhoA, RhoB and RhoC differentially regulate endothelial barrier function
por: Pronk, Manon C. A., et al.
Publicado: (2017)